Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. [electronic resource]
Producer: 20200629Description: 1921-1932 p. digitalISSN:- 1524-4539
- Acute Coronary Syndrome -- complications
- Aged
- Anticoagulants -- adverse effects
- Aspirin -- therapeutic use
- Atrial Fibrillation -- complications
- Cardiovascular Agents -- therapeutic use
- Combined Modality Therapy
- Disease Management
- Drug Therapy, Combination
- Elective Surgical Procedures
- Female
- Fibrinolytic Agents -- adverse effects
- Hemorrhage -- chemically induced
- Hospitalization
- Humans
- Male
- Middle Aged
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors -- adverse effects
- Proportional Hazards Models
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- adverse effects
- Pyrazoles -- therapeutic use
- Pyridones -- therapeutic use
- Treatment Outcome
- Vitamin K -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.